Industry Roundup: Keep Extra-Strength Acetaminophen OTC – McNeil-Backed Survey
This article was originally published in The Tan Sheet
Keep extra-strength acetaminophen OTC – McNeil-backed survey; direct sellers Jenuesse, MonaVie combine; Four Elements makes drug claims; and more news in brief.
You may also be interested in...
Lane Labs in contempt, judge says; NAD delineates between “entire” and “100%”; ERSP eyes stem cell claims; Probiotics lift Schiff brands; more news In Brief.
In a bid to keep 500-mg tablets and 1,000-mg doses of acetaminophen available over the counter, McNeil Consumer Healthcare argues revised dosing instructions would address the root cause of unintentional overdose without unduly restricting access to the popular painkiller
Competitive value propositions are a must in 2023 to win guarded consumers’ business. Companies that effectively address mental health and wellbeing needs and appeal to consumers through sustainability initiatives could have an edge in the recessionary environment, experts suggest. Meanwhile, there are concerns about small cosmetics companies and the availability of resources to help them comply with "modernized" federal regulations.